Editas Medicine, Inc. (EDIT) Profit Margins
Over the twelve months to 2026-06-30, Editas Medicine, Inc. (EDIT) had operating margin -161.4%, net margin -157.3%, free cash flow margin -256.5%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
EDITEditas Medicine, Inc.Follow EDIT — free
—
Price chart with a free account
- Market cap
- 368.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | 62.1% | — | — | |
| Operating margin | -356.1% | -686.4% | -148.6% | -756.1% | -1146.3% | -216.6% | -777.2% | -394.9% | -161.4% | |
| Net margin | -344.3% | -651.4% | -127.8% | -753.6% | -1118.3% | -196.1% | -733.7% | -395.0% | -157.3% | |
| FCF margin | -158.0% | -228.1% | -206.1% | -672.5% | -920.6% | -175.2% | -678.1% | -409.3% | -256.5% |
USD millions · SEC XBRL
Editas Medicine, Inc. — questions
- What is Editas Medicine, Inc.'s operating margin?
- -161.4% over the twelve months to 2026-06-30.
- What is Editas Medicine, Inc.'s net profit margin?
- -157.3% over the twelve months to 2026-06-30.
Every figure on this page comes from Editas Medicine, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.